- An in vitro synthetic biology platform for the industrial biomanufacturing of myo-inositol from starch.
An in vitro synthetic biology platform for the industrial biomanufacturing of myo-inositol from starch.
Biotechnology and bioengineering (2017-04-15)
Chun You, Ting Shi, Yunjie Li, Pingping Han, Xigui Zhou, Yi-Heng Percival Zhang
PMID28409846
ABSTRACT
Myo-Inositol (vitamin B8) is widely used in the drug, cosmetic, and food & feed industries. Here, we present an in vitro non-fermentative enzymatic pathway that converts starch to inositol in one vessel. This in vitro pathway is comprised of four enzymes that operate without ATP or NAD
MATERIALS